We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada’s New Drug Pricing Regulations Will Hurt Innovation, Industry Group Says
Canada’s New Drug Pricing Regulations Will Hurt Innovation, Industry Group Says
Canada’s leading drug industry lobby group claims the government’s latest initiative to lower prescription drug costs will weaken innovation and investment in new drugs.